|
|
|
Volumn 93 Suppl 6, Issue , 2010, Pages
|
|
The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
NEUROLEPTIC AGENT;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
ARTICLE;
ASIAN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
HUMAN;
MAJOR DEPRESSION;
OUTPATIENT;
QUALITY ADJUSTED LIFE YEAR;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL MODEL;
THAILAND;
TREATMENT OUTCOME;
ANTIDEPRESSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
COST-BENEFIT ANALYSIS;
DEPRESSIVE DISORDER, MAJOR;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
HUMANS;
MODELS, ECONOMIC;
OUTPATIENTS;
PIPERAZINES;
QUALITY-ADJUSTED LIFE YEARS;
QUINOLONES;
THAILAND;
TREATMENT OUTCOME;
|
|
EID: 84855489745
PISSN: 01252208
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
